Taichung, Taiwan

Juan-Cheng Yang

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Location History:

  • Tainan, TW (2015)
  • Taichung, TW (2022)

Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Innovations of Juan-Cheng Yang

Introduction

Juan-Cheng Yang is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of medical research, particularly in the development of compounds that have therapeutic applications. With a total of 2 patents, his work focuses on innovative solutions to health-related challenges.

Latest Patents

One of his latest patents is titled "Composition including ADAM9 inhibitor and the use thereof." This patent discloses an ADAM9 inhibitor compound, including its salts, hydrates, and stereoisomers. The invention outlines methods for using this compound to treat individuals in need, aiming to improve their health or condition. Another significant patent is "Use of compound for inhibiting glutathione s-transferase omega 1 activity and method for synthesizing the same." This patent presents a compound designed to inhibit the activity of glutathione s-transferase omega 1, providing a new avenue for therapeutic intervention.

Career Highlights

Juan-Cheng Yang is affiliated with China Medical University, where he conducts research and develops innovative medical solutions. His work has garnered attention for its potential impact on health treatments and disease management.

Collaborations

He collaborates with esteemed colleagues such as Yang-Chang Wu and Yuh-Pyng Sher, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Juan-Cheng Yang's contributions to medical research through his patents highlight his commitment to advancing health solutions. His innovative work continues to pave the way for future developments in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…